616 related articles for article (PubMed ID: 24664136)
41. Non-steroidal anti-inflammatory drugs for heterotopic ossification prophylaxis after total hip arthroplasty: a systematic review and meta-analysis.
Joice M; Vasileiadis GI; Amanatullah DF
Bone Joint J; 2018 Jul; 100-B(7):915-922. PubMed ID: 29954195
[TBL] [Abstract][Full Text] [Related]
42. Heterotopic Ossification in Hip Arthroscopy.
Seijas R; Barastegui D; Celis CL; Montaña F; Cuscó X; Cugat R
Surg J (N Y); 2023 Jan; 9(1):e8-e12. PubMed ID: 36756198
[No Abstract] [Full Text] [Related]
43. Cost of radiotherapy versus NSAID administration for prevention of heterotopic ossification after total hip arthroplasty.
Strauss JB; Chen SS; Shah AP; Coon AB; Dickler A
Int J Radiat Oncol Biol Phys; 2008 Aug; 71(5):1460-4. PubMed ID: 18234435
[TBL] [Abstract][Full Text] [Related]
44. Non-steroidal anti-inflammatory drugs for preventing heterotopic bone formation after hip arthroplasty.
Fransen M; Neal B
Cochrane Database Syst Rev; 2004; (3):CD001160. PubMed ID: 15266441
[TBL] [Abstract][Full Text] [Related]
45. Heterotopic ossification in patients with hip osteoarthritis below forty years old after total hip replacement.
Koczy B; Stołtny T; Swiderski M; Pyda M; Pajak J; Spindel J; Wawrzynek W; Miszczyk L; Kasperczyk S; Widuchowski J
Ortop Traumatol Rehabil; 2009; 11(5):458-66. PubMed ID: 19920288
[TBL] [Abstract][Full Text] [Related]
46. Surgical Resection Combined with Adjuvant Radiotherapy and Non-Steroidal Anti-Inflammatory Drugs in the Treatment of Heterotopic Ossification Following Total Hip Arthroplasty.
Osório T; Lemos J; Tkachuk O; Sousa R; Vasques A
Acta Med Port; 2023 Mar; 36(3):202-205. PubMed ID: 35748410
[TBL] [Abstract][Full Text] [Related]
47. Heterotopic Ossification in Hip Arthroscopy: an Updated Review.
Kurz AZ; LeRoux E; Riediger M; Coughlin R; Simunovic N; Duong A; Laskovski JR; Ayeni OR
Curr Rev Musculoskelet Med; 2019 Jun; 12(2):147-155. PubMed ID: 30810970
[TBL] [Abstract][Full Text] [Related]
48. Surgical technique: arthroscopic treatment of heterotopic ossification of the hip after prior hip arthroscopy.
Ong C; Hall M; Youm T
Clin Orthop Relat Res; 2013 Apr; 471(4):1277-82. PubMed ID: 23054520
[TBL] [Abstract][Full Text] [Related]
49. Editorial Commentary: The Curious Incident of the Bone in the Soft Tissue: Is Heterotopic Ossification After Hip Arthroscopy an Interesting Finding or Is It a Complication?
Ochiai D; Adib F
Arthroscopy; 2020 Feb; 36(2):462-463. PubMed ID: 32014177
[TBL] [Abstract][Full Text] [Related]
50. NSAIDs for Prophylaxis for Heterotopic Ossification After Total Hip Arthroplasty: A Bayesian Network Meta-analysis.
Migliorini F; Trivellas A; Eschweiler J; Driessen A; Tingart M; Maffulli N
Calcif Tissue Int; 2021 Feb; 108(2):196-206. PubMed ID: 33044630
[TBL] [Abstract][Full Text] [Related]
51. Total hip arthroplasty. The role of antiinflammatory medications in the prevention of heterotopic ossification.
Kjaersgaard-Andersen P; Schmidt SA
Clin Orthop Relat Res; 1991 Feb; (263):78-86. PubMed ID: 1899640
[TBL] [Abstract][Full Text] [Related]
52. Outcomes of Preoperative Versus Postoperative Radiation for Heterotopic Ossification Prevention in Children With Neuromuscular Hip Dysplasia Undergoing Proximal Femoral Resection.
Hess CB; Stein-Wexler R; Qi L; Davids JR; Fragoso RC
J Pediatr Orthop; 2019 Feb; 39(2):e102-e107. PubMed ID: 29068805
[TBL] [Abstract][Full Text] [Related]
53. Radiation Prophylaxis for Hip Salvage Surgery in Cerebral Palsy: Can We Reduce the Incidence of Heterotopic Ossification?
Davis E; Williams K; Matheney TH; Snyder B; Marcus KJ; Shore BJ
J Pediatr Orthop; 2019; 39(5):e386-e391. PubMed ID: 30543561
[TBL] [Abstract][Full Text] [Related]
54. [Eight days of naproxen therapy can prevent heterotopic ossification after total hip alloplasty].
Gebuhr PH; Wilbek H; Soelberg M
Ugeskr Laeger; 1996 Feb; 158(8):1076-8. PubMed ID: 8638341
[TBL] [Abstract][Full Text] [Related]
55. WITHDRAWN: Non-steroidal anti-inflammatory drugs for preventing heterotopic bone formation after hip arthroplasty.
Fransen M; Neal B
Cochrane Database Syst Rev; 2013 Mar; 2013(3):CD001160. PubMed ID: 23543510
[TBL] [Abstract][Full Text] [Related]
56. Safety and efficacy of radiation therapy as secondary prophylaxis for heterotopic ossification of non-hip joints.
Mishra MV; Austin L; Parvizi J; Ramsey M; Showalter TN
J Med Imaging Radiat Oncol; 2011 Jun; 55(3):333-6. PubMed ID: 21696569
[TBL] [Abstract][Full Text] [Related]
57. Capsular closure does not affect development of heterotopic ossification after hip arthroscopy.
Amar E; Warschawski Y; Sampson TG; Atoun E; Steinberg EL; Rath E
Arthroscopy; 2015 Feb; 31(2):225-30. PubMed ID: 25442652
[TBL] [Abstract][Full Text] [Related]
58. Incidence and location of heterotopic ossification following hip arthroscopy.
Zheng L; Hwang JM; Hwang DS; Kang C; Lee JK; Park YC
BMC Musculoskelet Disord; 2020 Feb; 21(1):132. PubMed ID: 32111223
[TBL] [Abstract][Full Text] [Related]
59. What MRI Findings Predict Failure 10 Years After Surgery for Femoroacetabular Impingement?
Hanke MS; Steppacher SD; Anwander H; Werlen S; Siebenrock KA; Tannast M
Clin Orthop Relat Res; 2017 Apr; 475(4):1192-1207. PubMed ID: 27580735
[TBL] [Abstract][Full Text] [Related]
60. Pharmacologic prophylaxis for heterotopic ossification following spinal cord injury: A systematic review and meta-analysi.
Yolcu YU; Wahood W; Goyal A; Alvi MA; Reeves RK; Qu W; Gerberi DJ; Bydon M
Clin Neurol Neurosurg; 2020 Jun; 193():105737. PubMed ID: 32169744
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
